Literature DB >> 6137223

Binding of phenothiazine neuroleptics to plasma proteins.

R K Verbeeck, J A Cardinal, A G Hill, K K Midha.   

Abstract

The binding of chlorpromazine, trifluoperazine, perphenazine, desipramine, propranolol and salicylic acid to human plasma and isolated plasma proteins was studied using equilibrium dialysis. Unlike salicylic acid, an acidic compound only bound to human serum albumin, the basic drugs were bound to all plasma protein fractions studied (albumin, alpha 1-acid glycoprotein, lipoproteins, gamma-globulins) with alpha 1-acid glycoprotein an important binding protein for each of them. The interaction of chloropromazine, perphenazine and trifluoperazine with alpha 1-acid glycoprotein was studied using Scatchard analysis. The primary class of binding sites revealed a low capacity (n = 0.5-1) and a high affinity (K = 10(5)-10(6) M-1) for the phenothiazines. The interaction of chlorpromazine, perphenazine and trifluoperazine with albumin was of the high capacity-low affinity type. In binding studies using plasma obtained from healthy volunteers, alpha 1-acid glycoprotein was found to be a very important binding protein for the basic drug studied with the exception of desipramine. This shows that results derived from binding studies using isolated protein fractions should be interpreted with caution.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6137223     DOI: 10.1016/0006-2952(83)90019-9

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

1.  Profound effect of plasma protein binding on the polarized transport of furosemide and verapamil in the Caco-2 model.

Authors:  S M Chung; E J Park; S M Swanson; T C Wu; W L Chiou
Journal:  Pharm Res       Date:  2001-04       Impact factor: 4.200

2.  Assessment of Three-Drug Combination Pharmacodynamic Interactions in Pancreatic Cancer Cells.

Authors:  Emilie A G Molins; William J Jusko
Journal:  AAPS J       Date:  2018-06-27       Impact factor: 4.009

3.  Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.

Authors:  G Sager; R Jaeger; C Little
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

Review 4.  Antipsychotic drugs. Clinical pharmacokinetics of potential candidates for plasma concentration monitoring.

Authors:  A E Balant-Gorgia; L Balant
Journal:  Clin Pharmacokinet       Date:  1987-08       Impact factor: 6.447

5.  Effect of age and sex on the plasma binding of acidic and basic drugs.

Authors:  R K Verbeeck; J A Cardinal; S M Wallace
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Entrapment of alpha1-acid glycoprotein in high-performance affinity columns for drug-protein binding studies.

Authors:  Cong Bi; Abby Jackson; John Vargas-Badilla; Rong Li; Giana Rada; Jeanethe Anguizola; Erika Pfaunmiller; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-11-27       Impact factor: 3.205

7.  Use of a novel radiometric method to assess the inhibitory effect of donepezil on acetylcholinesterase activity in minimally diluted tissue samples.

Authors:  Tatsuya Kikuchi; Toshimitsu Okamura; Takuya Arai; Takayuki Obata; Kiyoshi Fukushi; Toshiaki Irie; Tetsuya Shiraishi
Journal:  Br J Pharmacol       Date:  2010-04       Impact factor: 8.739

8.  A cross-validation study on the relationship between central D2 receptor occupancy and serum perphenazine concentration.

Authors:  Mirjam Talvik; Anna-Lena Nordström; Niels-Erik Larsen; Aurelija Jucaite; Simon Cervenka; Christer Halldin; Lars Farde
Journal:  Psychopharmacology (Berl)       Date:  2004-03-06       Impact factor: 4.530

9.  Transcellular permeability of chlorpromazine demonstrating the roles of protein binding and membrane partitioning.

Authors:  G A Sawada; N F Ho; L R Williams; C L Barsuhn; T J Raub
Journal:  Pharm Res       Date:  1994-05       Impact factor: 4.200

10.  Calcium dependent interaction of calmodulin with the GlyT1 C-terminus.

Authors:  Andrea Mihalikova; Martina Baliova; Frantisek Jursky
Journal:  Neurochem Res       Date:  2014-08-29       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.